Protective potential of 17β-estradiol against co-exposure of 4-hydroxynonenal and 6-hydroxydopamine in PC12 cells

Human and Experimental Toxicology

Volumn 30, Issue 8, 2011, Pages 860-869

  Siddiqui, M A ^a   Kashyap, M P ^b   Al Khedhairy, A A ^a   Musarrat, J ^a   Khanna, V K ^b   Yadav, S ^b   Pant, A B ^b  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

^b CSIR INDIAN INSTITUTE OF TOXICOLOGY RESEARCH   (India)

Author keywords

17 estradiol; 4 HNE; 6 OHDA; cytotoxicity; PC12 cells

Indexed keywords

4 HYDROXYNONENAL; ESTRADIOL; OXIDOPAMINE;

ANIMAL CELL; ARTICLE; CELL ACTIVITY; CELL DAMAGE; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFECT; DRUG EFFICACY; DRUG EXPOSURE; IN VITRO STUDY; MITOCHONDRION; NEUROPROTECTION; NONHUMAN; PREMEDICATION; PRIORITY JOURNAL; RAT; TREATMENT RESPONSE;

ALDEHYDES; ANIMALS; CELL CULTURE TECHNIQUES; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; ESTRADIOL; LIPID PEROXIDATION; NEUROPROTECTIVE AGENTS; OXIDOPAMINE; PC12 CELLS; RATS;

EID: 79960797581     PISSN: 09603271     EISSN: 14770903     Source Type: Journal    
DOI: 10.1177/0960327110382130     Document Type: Article

References (50)

1. Adibhatla RM, Hatcher JF Lipid oxidation and peroxidation in CNS Health and disease: from molecular mechanisms to therapeutic opportunities. Antiox Redox Signal 2010 ; 12: 125-169.
2. Dmitriev LF The involvement of lipid radical cycles and the adenine nucleotide translocator in neurodegenerative diseases. J Alzheimer's Dis 2007 ; 11: 183-190. (Pubitemid 47010985)
3. Liang LP, Huang J., Fulton R., Day BJ, and Patel M. An orally active catalytic metalloporphyrin protects against 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine neurotoxicity in vivo. J Neurosci 2007 ; 27: 4326-4333. (Pubitemid 46640723)
4. Piga R., Saito Y., Yoshida Y., and Niki E. Cytotoxic effects of various stressors on PC12 cells: involvement of oxidative stress and effect of antioxidants. Neurotoxicology 2007 ; 28: 67-75. (Pubitemid 46187259)
5. Arakawa M., Ishimura A., Arai Y., Kawabe K., Suzuki S., Ishige K., et al. N-Acetylcysteine and ebselen but not nifedipine protected cerebellar granule neurons against 4-hydroxynonenal-induced neuronal death. Neurosci Res 2007 ; 57: 220-229. (Pubitemid 46177290)
6. Abdul HM, Butterfield DA Involvement of PI3K/PKG/ ERK1/2 signaling pathways in cortical neurons to trigger protection by co-treatment of acetyl-L-carnitine and alpha-lipoic acid against HNE-mediated oxidative stress and neurotoxicity: implications for Alzheimer's disease. Free Radic Biol Med 2007 ; 42: 371-384. (Pubitemid 46038045)
7. Siddiqui MA, Singh G., Kashyap MP, Khanna VK, Yadav S., Chandra D., et al. Influence of cytotoxic doses of 4-hydroxynonenal on selected neurotransmitter receptors in PC-12 cells. Toxicol In Vitro 2008 ; 22: 1681-1688.
8. Mazzio EA, Reams RR, and Soliman KF The role of oxidative stress, impaired glycolysis and mitochondrial respiratory redox failure in the cytotoxic effects of 6-hydroxydopamine in vitro. Brain Res 2004 ; 1004: 29-44. (Pubitemid 38368060)
9. Inden M., Kitamura Y., Kondo J., Hayashi K., Yanagida T., Takata K., et al. Serofendic acid prevents 6-hydroxydopamine-induced nigral neurodegeneration and drug-induced rotational asymmetry in hemiparkinsonian rats. J Neurochem 2005 ; 95: 950-961. (Pubitemid 41713481)
10. Blum D., Torch S., Lambeng N., Nissou M., Benabid AL, Sadoul R., et al. Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson's disease. Prog Neurobiol 2001 ; 65: 135-172. (Pubitemid 32524182)
11. Hanrott K., Gudmunsen L., O'Neill MJ, and Wonnacott S. 6-hydroxydopamine-induced apoptosis is mediated via extracellular auto-oxidation and caspase 3-dependent activation of protein kinase C delta. J Biol Chem 2006 ; 281: 5373-5382. (Pubitemid 43847631)
12. Wang T., Zhang QJ, Liu J., Wu ZH, and Wang S. Firing activity of locus coeruleus noradrenergic neurons increases in a rodent model of Parkinsonism. Neurosci Bull 2009 ; 25: 15-20.
13. Kulkarni J., de Castella A., Fitzgerald PB, Gurvich CT, Bailey M., Bartholomeusz C., et al. Estrogen in severe mental illness: a potential new treatment approach. Arch Gen Psychiatry 2008 ; 65: 955-960.
14. Bagger YZ, Tanko LB, Alexandersen P., Qin G., and Christiansen C. Early postmenopausal hormone therapy may prevent cognitive impairment later in life. Menopause 2005 ; 12: 12-17. (Pubitemid 40204888)
15. McClean J., Nuñez JL 17alpha-Estradiol is neuroprotective in male and female rats in a model of early brain injury. Exp Neurol 2008 ; 210: 41-50. (Pubitemid 351258066)
16. Huppmann S., Römer S., Altmann R., Obladen M., and Berns M. 17beta-estradiol attenuates hyperoxiainduced apoptosis in mouse C8-D1A cell line. J Neurosci Res 2008 ; 86: 3420-3426.
17. Morissette M., Di Paolo T. Effect of estradiol on striatal dopamine activity of female hemiparkinsonian monkeys. J Neurosci Res 2008 ; 87: 1634-1644.
18. Cheng MY, Sun G., Jin M., Zhao H., Steinberg GK, and Sapolsky RM Blocking glucocorticoid and enhancing estrogenic genomic signaling protects against cerebral ischemia. J Cereb Blood Flow Metab 2009 ; 29: 130-136.
19. Wise PM, Dubal DB, Wilson ME, Rau SW, Böttner M., and Rosewell KL Estradiol is a protective factor in the adult and aging brain: understanding of mechanisms derived from in vivo and in vitro studies. Brain Res Brain Res Rev 2001 ; 37: 313-319. (Pubitemid 34020741)
20. Wang X., Dykens JA, Perez E., Liu R., Yang S., Covey DF, et al. Neuroprotective effects of 17beta-estradiol and nonfeminizing estrogens against H2O2 toxicity in human neuroblastoma SK-N-SH cells. Mol Pharmacol 2006 ; 70: 395-404.
21. Saengsirisuwan V., Pongseeda S., Prasannarong M., Vichaiwong K., and Toskulkao C. Modulation of insulin resistance in ovariectomized rats by endurance exercise training and estrogen replacement. Metabolism 2009 ; 58: 38-47.
22. Zhang H., Xie M., Schools GP, Feustel PF, Wang W., Lei T., et al. Tamoxifen mediated estrogen receptor activation protects against early impairment of hippocampal neuron excitability in an oxygen/glucose deprivation brain slice ischemia model. Brain Res 2009 ; 1247: 196-211.
23. Zhao Y., Hu I., and Jin W. Transformation of oxidation products and reduction of estrogenic activity of 17beta-estradiol by a heterogeneous photo-Fenton reaction. Environ Sci Technol 2008 ; 42: 5277-5284.
24. Hruska Z., Dohanich GP The effects of chronic estradiol treatment on working memory deficits induced by combined infusion of beta-amyloid (1-42) and ibotenic acid. Horm Behav 2007 ; 52: 297-306. (Pubitemid 47271899)
25. Perrella J., Bhavnani BR Protection of cortical cells by equine estrogens against glutamate-induced excitotoxicity is mediated through a calcium independent mechanism. BMC Neurosci 2005 ; 6: 34.
26. Wang J., Green PS, and Simpkins JW Estradiol protects against ATP depletion, mitochondrial membrane potential decline and the generation of reactive oxygen species induced by 3-nitroproprionic acid in SK-N-SH human neuroblastoma cells. J Neurochem 2001 ; 77: 804-811. (Pubitemid 32466777)
27. Regan RF, Guo Y. Estrogens attenuate neuronal injury due to hemoglobin, chemical hypoxia, and excitatory amino acids in murine cortical cultures. Brain Res 1997 ; 764: 133-140. (Pubitemid 27380648)
28. Zhang P., Li HF, Tian ZF, Qiu XQ, Wu JX, and Jia ZJ Effects of phytoestrogens and 17beta-estradiol on vasoconstriction elicited by reactive oxygen species. Pharmazie 2007 ; 62: 378-381. (Pubitemid 46847943)
29. Galbiati F., Volonte D., Gil O., Zanazzi G., Salzer JL, Sargiacomo M., et al. Expression of caveolin-1 and -2 in differentiating PC12 cells and dorsal root ganglion neurons: caveolin-2 is up-regulated in response to cell injury. Proc Natl Acad Sci U S A 1998 ; 95: 10257-10262.
30. Pant AB, Agarwal AK, Sharma VP, and Seth PK In vitro cytotoxicity evaluation of plastic biomedical devices. Hum Exp Toxicol 2001 ; 20: 412-417. (Pubitemid 33064739)
31. Li D., Hinshelwood A., Gardner R., McGarvie G., and Ellis EM Mouse aldo-keto reductase AKR7A5 protects V79 cells against 4-hydroxynonenal-induced apoptosis. Toxicology 2006 ; 226: 172-180. (Pubitemid 44382614)
32. Borovic S., Cipak A., Meinitzer A., Kejla Z., Perovic D., Waeg G., et al. Differential sensitivity to 4-hydroxynonenal for normal and malignant mesenchymal cells. Redox Rep 2007 ; 12: 50-54. (Pubitemid 46210355)
33. Shi Q., Vaillancourt F., Cote V., Fahmi H., Lavigne P., Afif H., et al. Alterations of metabolic activity in human osteoarthritic osteoblasts by lipid peroxidation end product 4-hydroxynonenal. Arthritis Res Ther 2006 ; 8: 159.
34. Chung FL, Pan J., Choudhury S., Roy R., Hu W., and Tang MS Formation of trans-4-hydroxy-2-nonenaland other enal-derived cyclic DNA adducts from omega-3 and omega-6 polyunsaturated fatty acids and their roles in DNA repair and human p53 gene mutation. Mutat Res 2005 ; 531: 25-36. (Pubitemid 37456722)
35. Siddiqui MA, Singh G., Khanna VK, Kashyap MP, Yadav S., Chandra D., et al. Oxidative stress mediated cellular responses in 4-hydoxynonenal exposed PC12 cells. J Ecophysiol Occup Health 2007 ; 7: 97-109. (Pubitemid 351151668)
36. VChoudhary S., Xiao T., Srivastava S., Zhang W., Chan LL, Vergara LA, et al. Toxicity and detoxification of lipid-derived aldehydes in cultured retinal pigmented epithelial cells. Toxicol Appl Pharmacol 2005 ; 204: 122-134.
37. Dwivedi S., Sharma A., Patrick B., Sharma R., and Awasthi YC Role of 4-hydroxynonenal and its metabolites in signaling. Redox Rep 2007 ; 12: 4-10. (Pubitemid 46210346)
38. Srivastava S., Dixit BL, Cai J., Sharma S., Hurst HE, Bhatnagar A., et al. Metabolism of lipid peroxidation product, 4-hydroxynonenal (HNE) in rat erythrocytes: role of aldose reductase. Free Radic Biol Med 2000 ; 29: 642-651.
39. Seth K., Agrawal AK, Aziz MH, Ahmad A., Shukla Y., Mathur N., et al. Induced expression of early response genes/oxidative injury in rat pheochromocytoma (PC12) cell line by 6-hydroxydopamine: implication for Parkinson's disease. Neurosci Lett 2002 ; 330: 89-93. (Pubitemid 35245776)
40. Bové J., Prou D., Perier C., and Przedborski S. Toxin-induced models of Parkinson's disease. NeuroRx 2005 ; 2: 484-494. (Pubitemid 41444882)
41. Chaturvedi RK, Shukla S., Seth K., Chauhan S., Sinha C., Shukla Y., et al. Neuroprotective and neurorescue effect of black tea extract in 6-hydroxydopaminelesioned rat model of Parkinson's disease. Neurobiol Dis 2006 ; 22: 421-434.
42. Eminel S., Klettne A., Roemer L., Herdegen T., and Waetzig V. JNK2 translocates to the mitochondria and mediates cytochrome c release in PC12 cells in response to 6-hydroxydopamine. J Biol Chem 2004 ; 279: 55385-55392. (Pubitemid 40066538)
43. Finkelstein EI, Ruben J., Koot CW, Hristova M., and van der Vliet A. Regulation of constitutive neutrophil apoptosis by the alpha,beta-unsaturated aldehydes acrolein and 4-hydroxynonenal. Am J Physiol Lung Cell Mol Physiol 2005 ; 289: 1019-1028.
44. Duarte AI, Santos MS, Oliveira CR, and Rego AC Insulin neuroprotection against oxidative stress in cortical neurons-involvement of uric acid and glutathione antioxidant defenses. Free Radic Biol Med 2005 ; 39: 876-889.
45. Mattson MP, Robinson N., and Guo Q. Estrogens stabilize mitochondrial function and protect neural cells against the pro-apoptotic action of mutant presenilin-1. Neuroreport 1997 ; 8: 3817-3821. (Pubitemid 28004881)
46. Carmen D., Lobatón LV, Hernández-SanMiguel E., SantoDomingo J., Moreno A., Montero M., et al. Modulation of mitochondrial Ca2+ uptake by estrogen receptor agonists and antagonists. Br J Pharmacol 2005 ; 145: 862-871. (Pubitemid 41129007)
47. Razmara A., Duckles SP, Krause DN, and Procaccio V. Estrogen suppresses brain mitochondrial oxidative stress in female and male rats. Brain Res 2007 ; 1176: 71-81. (Pubitemid 47553127)
48. Nilsen J., Diaz BR Mechanism of estrogen-mediated neuroprotection: regulation of mitochondrial calcium and Bcl-2 expression. Proc Natl Acad Sci U S A 2003 ; 100: 2482-2487.
49. Burris TP, Krishnan V. Estrogen: a mitochondrial energizer that keeps on going. Mol Pharmacol 2005 ; 68: 956-958. (Pubitemid 41345786)
50. Stirone C., Duckles SP, Krause DN, and Procaccio V. Estrogen increases mitochondrial efficiency and reduces oxidative stress in cerebral blood vessels. Mol Pharmacol 2005 ; 68: 959-965. (Pubitemid 41345787)